99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: Clinical validation of the relationship between 99mTc-MIBI uptake and P-glycoprotein expression in tumour tissue

European Journal of Nuclear Medicine

Volumn 23, Issue 8, 1996, Pages 976-979

  Derebek, Erkan ^a   Kirkali, Ziya ^a   Dogan, A Semih ^a   Degirmenci, Berna ^a   Yilmaz, Mustafa ^a   Igci, Enis ^a   Yorukoglu, Kutsal ^a   Kovanlikaya, Ilhami ^a   Durak, Hatice ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Multidrug resistance; P glycoprotein; Renal cell carcinoma; Technetium 99m hexakis 2 methoxyisobutylisonitrile

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; THALLIUM;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; KIDNEY SCINTISCANNING; LUNG METASTASIS; MALE; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; LUNG TUMOR; METASTASIS; SCINTISCANNING;

AGED; CARCINOMA, RENAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; P-GLYCOPROTEIN; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES;

EID: 0029666469     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01084374     Document Type: Article

References (19)

1. Chapman AE, Goldstein LJ. Multidrug resistance: Biologic basis and clinical significance in renal cell carcinoma. Semin Oncol 1995; 22: 17-28.
2. Roninson IB, Pastan I, Gottesman MM. Isolation and characterisation of the human MDR (P-glycoprotein) genes. In: Roninson IB, ed. Molecular and cellular biology of multidurg resistance in tumor cells. New York: Plenum Press; 1991: 91-106.
3. Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistance P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 1-8.
4. Moretti JL, Çaglar M, Boazis C, et al. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-III octreotide. Can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995:22: 177-180.
5. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, et al. Evaluation of tumor metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 1995; 22: 434-442.
6. Swanson DA. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma? Semin Urol 1993; 11: 35-40.
7. Lum BL, Fisher GA, Brophy NA. Clinical trials of modulation of multidrug resistance: pharmacokinetic and pharmacodynamic considerations. Cancer 1993; 72 Suppl: 3502-3514.
8. Gottesman MM, Willingham MC, Pastan I. Expression of the MDRI gene in normal human tissue. In: Roninson IB, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press; 1991: 279-290.
9. Gottesman MM, Goldstein LJ, Foja A. Expression of the multidrug resistance gene in human cancers. In: Roninson IB. ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press, 1991: 291-302.
10. Cordon-Cardo C. Immunohistochemical analysis of P-glycoprotein expression in normal and tumor tissues in humans. In: Roninson IB. ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press; 1991: 303-316.
11. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994; 35: 510-515.
12. Piwnica-Worms D, Chiu ML, Kronauge JF. Membrane potential-sensitive retention of Tc-99m MIBI in culture chick heart cells [abstract]. Radiology 1989; 173(P): 281.
13. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 1990; 31: 1166-1167.
14. Fojo AT, Shen DW, Mickley LA, et al. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J Clin Oncol 1987; 5: 1922-1927.
15. Kakehi Y, Kanamaru Y, Yoshida O, et al. Measurement of multidrug-resistance messenger RNA in urogenital cancers: elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J Urol 1988; 139: 862-865.
16. Nishiyama K, Shirahama T, Yoshimura A. et al. Expression of the multidrug transport P-glycoprotein in renal and transitional cell carcinoma. Cancer 1993; 71: 3611-3619.
17. Bak M Jr, Efferth T, Mikisch G, et al. Detection of drug resistance P-glycoprotein in human renal cell carcinoma. Eur Urol 1990; 17:72-75.
18. Kanamaru H, Kakehi Y, Yoshida O, et al. MDRI RNA levels in human renal carcinoma: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 1989; 81: 844-849.
19. Rochlitz CF, Lobeck H, Peter S, et al. Multi drug resistance gene expression in human renal cancer is associated with the histologic subtype. Cancer 1992; 69: 2963-2998.